Literature DB >> 7579776

Digoxin in the treatment of patients with chronic heart failure. Its place in therapy.

B F Uretsky1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7579776     DOI： 10.2165/00002512-199507010-00001

Source DB:  PubMed          Journal:  Drugs Aging        ISSN： 1170-229X            Impact factor:   3.923


× No keyword cloud information.
  44 in total

1.  Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group.

Authors: 
Journal:  JAMA       Date:  1988 Jan 22-29       Impact factor: 56.272

Review 2.  Need for a large randomized trial to evaluate the effects of digitalis on morbidity and mortality in congestive heart failure.

Authors:  S Yusuf; R Garg; P Held; R Gorlin
Journal:  Am J Cardiol       Date:  1992-06-04       Impact factor: 2.778

3.  Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients.

Authors:  S M Dobbs; W I Kenyon; R J Dobbs
Journal:  Br Med J       Date:  1977-03-19

4.  The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.

Authors:  G H Guyatt; M J Sullivan; P J Thompson; E L Fallen; S O Pugsley; D W Taylor; L B Berman
Journal:  Can Med Assoc J       Date:  1985-04-15       Impact factor: 8.262

5.  Comparison of lisinopril versus digoxin for congestive heart failure during maintenance diuretic therapy. The Lisinopril-Digoxin Study Group.

Authors:  J Herlitz
Journal:  Am J Cardiol       Date:  1992-10-08       Impact factor: 2.778

6.  Captopril versus digoxin in patients with coronary artery disease and mild heart failure. A prospective, double-blind, placebo-controlled multicenter study. The CADS Study Group.

Authors:  H Just; H Drexler; S H Taylor; J Siegrist; G Schulgen; M Schumacher
Journal:  Herz       Date:  1993-12       Impact factor: 1.443

7.  Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm.

Authors:  J L Fleg; S H Gottlieb; E G Lakatta
Journal:  Am J Med       Date:  1982-08       Impact factor: 4.965

8.  A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.

Authors:  R DiBianco; R Shabetai; W Kostuk; J Moran; R C Schlant; R Wright
Journal:  N Engl J Med       Date:  1989-03-16       Impact factor: 91.245

9.  Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group.

Authors:  A M Feldman; M R Bristow; W W Parmley; P E Carson; C J Pepine; E M Gilbert; J E Strobeck; G H Hendrix; E R Powers; R P Bain
Journal:  N Engl J Med       Date:  1993-07-15       Impact factor: 91.245

10.  Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT).

Authors:  D J van Veldhuisen; A J Man in 't Veld; P H Dunselman; D J Lok; H J Dohmen; J C Poortermans; A J Withagen; W H Pasteuning; J Brouwer; K I Lie
Journal:  J Am Coll Cardiol       Date:  1993-11-15       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.